Clinical trials
Acute Pulmonary Embolism (PE) clinical trials
Below are recruiting acute pulmonary embolism (pe) clinical trials, each written for real people, not researchers. We’re tracking 42 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07431229Recruiting
Nitrates for moderate-to-high risk pulmonary embolism
This trial tests whether a common food additive (nitrates) can help your heart recover faster when you have a serious pulmonary embolism. It is for people with a recent clot and signs of heart strain, but who are not on specific blood thinners or other nitrate medicines.
StockholmAges 18 years+ - NCT07452991Recruiting
Ultrasound-guided clot-busting for moderate-risk pulmonary embolism
This trial tests a procedure that uses ultrasound to guide a catheter that delivers clot-dissolving medicine directly to a blood clot in the lungs. It is for people who have a pulmonary embolism that causes some heart strain but who are not in shock.
MoscowAges 18 years+ - NCT07491094Recruiting
Repeat scans for monitoring pulmonary embolism
This trial is testing if repeated imaging can help monitor blood clots in the lungs (pulmonary embolism) over time. It may help doctors know how well treatment is working and if further care is needed.
Gothenburg, Region Västra GötalandAges 18 years+ - NCT07519876Recruiting
Blood Clots in the Lungs and Heart Shunts Study
This study looks at whether people with blood clots in their lungs have hidden holes in their hearts that let blood bypass normal circulation. Researchers will use imaging tests to understand this connection and see if it affects how patients do.
Boston, MassachusettsAges 18 years+ - NCT07650435Recruiting
Clot removal in pulmonary embolism trial
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
PlymouthAges 18 years+ - NCT06372730Recruiting
Predicting blood clot return after stopping blood thinners
This study uses a special 3D lung scan (V/Q SPECT/CT) to see if leftover blockages in your lungs can predict if another blood clot will come back. You may be eligible if your doctor has decided it's safe to stop your blood thinners after 3 to 6 months of treatment for a first blood clot.
Amiens, FranceAges 18 years+ - NCT06695247Recruiting
Walking recovery after serious lung blood clot
This study follows people who had a serious blood clot in their lungs that also affected their heart's right side. It tests how their ability to walk and move changes over 6 months, helping doctors understand recovery better.
Rochester, MinnesotaAges 18–80 - NCT04615130Recruiting
Pulmonary rehab for symptoms after a lung blood clot
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
ViennaAges 18–90 - NCT07298096Recruiting
Vacuum thrombectomy for pulmonary embolism in cancer patients
This trial tests a computer-assisted vacuum device to remove blood clots from the lungs of people with cancer. It aims to see if this procedure is safe and improves quality of life for those with intermediate-risk pulmonary embolism.
Houston, TexasAges 18 years+ - NCT07270263Recruiting
Lower-dose blood thinners for people with blood cancers
This trial compares lower doses of two common blood thinner pills (apixaban and rivaroxaban) to a daily injection (enoxaparin) to prevent blood clots in people receiving treatment for blood cancers like multiple myeloma, lymphoma, or certain other blood cancers.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT02156401Recruiting
Study of tests and care to improve clot diagnosis
This study follows adults who may have a blood clot in the lung (pulmonary embolism) or leg (deep vein thrombosis), or who were found to have a clot by chance. It aims to improve how doctors diagnose, manage, and estimate risk, which may lead to better, more tailored care for you.
Mainz, Rhineland-PalatinateAges 18 years+ - NCT04798261Recruiting
Long-term follow-up after clot removal for pulmonary embolism
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
Long Beach, CaliforniaAges 18 years+ - NCT06541353Recruiting
Predicting heart function after a pulmonary embolism
This study uses heart signals and blood tests to predict how well your heart will recover over a year after a pulmonary embolism. It may help doctors tailor your care based on your personal risk.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06588634Recruiting
A study of a catheter device for high-risk pulmonary embolism
This trial tests a new treatment for people with a severe, high-risk pulmonary embolism (blood clot in the lung). It uses a catheter device to remove the clot and help the heart work better.
New Haven, ConnecticutAges 18 years+ - NCT06051032Recruiting
Comparing balloon vs. suction for clotted dialysis fistulas
This study compares two ways to clear a sudden clot in a dialysis fistula (AVF). It uses either a balloon (to push the clot out) or a suction device (to pull the clot out) to restore blood flow.
Valencia, ValenciaAges 18 years+ - NCT06386107Recruiting
Bleeding risk in people with cancer and blood clots on blood thinners
This study looks at how well blood thinners work in people with cancer and a recent blood clot. It measures the risk of bleeding by checking certain blood clotting factors.
Clermont-FerrandAges 18 years+ - NCT06886516RecruitingEarly Phase 1
Blood thinner study for cancer patients with low platelets
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
Boston, MassachusettsAges 18 years+ - NCT06473610Recruiting
Residual blood clots seen on lung scan study
This trial uses a special lung scan (SPECT-CT) to look for leftover blood clots in people with high blood pressure in the lungs or ongoing shortness of breath after a clot. It may help doctors better understand these conditions.
Saint-EtienneAges 18 years+
Hear when a new Acute Pulmonary Embolism (PE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute pulmonary embolism (pe)?
- Yes. Clin2 currently lists 42 recruiting acute pulmonary embolism (pe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute pulmonary embolism (pe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute pulmonary embolism (pe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.